Angiogenesis inhibitors and stimulators :potential therapeutic implications

  • 其他作者: Mousa, Shaker A.
  • 出版: Georgetown, Tex. :Austin, Tex. : Landes Bioscience ;Eurekah.com ©2000.
  • 稽核項: 1 online resource ([xi], 162 pages) :illustrations.
  • 叢書名: Medical intelligence unit ;20
  • 標題: Physiology. , Electronic books. , Angiogenesis Inhibitors , Néovascularisation Inhibiteurs. , Growth factors. , Néovascularisation , SCIENCE , MEDICAL , Néovascularisation. , Neovascularization. , Angiogenesis Inhibitors therapeutic use , Neovascularization inhibitors. , MEDICAL Physiology. , Facteurs de croissance. , SCIENCE Life Sciences -- Human Anatomy & Physiology. , Life SciencesHuman Anatomy & Physiology. , therapeutic use , Neovascularization, Pathologic , Inhibiteurs. , Growth Substances
  • ISBN: 1587063441 , 9781587063442
  • ISBN: 1587060221 , 9781587060229
  • 試查全文@TNUA:
  • 附註: Includes bibliographical references and index. Front Cover -- Inside Cover -- Copyright -- Table of Contents -- Editors / Contributors -- Preface -- Chapter 1: Mechanims of Angiogenesis -- Chapter 2: Angiogenisis and Ischemia -- Chapter 3: The Role of Smooth Muscle Cells and Pericytes in Angiogenesis -- Chapter 4: Integrin v in Health and Disease-Role of v3 in Metastasis, Vascular Remodeling and Angiogenesis -- Chapter 5: PECAM-1 and Angiogenesis -- Chapter 6: Thrombospondin and Angiogenesis -- Chapter 7: The Role of Vascular Endothelial Growth Factor in Angiogenesis -- Chapter 8: Regulation of Angiogenesis by Fibroblast Growth Factors. Chapter 9: Role of Angiogenesis in Wound Healing -- Chapter 10: Ocular Neovascularization -- Chapter 11: Anti-Angiogenesis Strategies Potential Therapeutic Implications -- Chapter 12: Matrix Metalloproteinase Inhibitors in Angiogenesis-Mediated Disorders with Special Emphasis on Cancer -- Chapter 13: Pharmaceutical Development of an Antiangiogenic Drug-Candidate -- Chapter 14: Surrogate Endpoints as a Measure of Efficacy in Clinical Trials of Angiogenesis Inhibitors -- Chapter 15: Lessons from Clinical Trials of Anti-Angiogenic Drugs in the Treatment of Cancer -- Index -- A -- Angiogenesis. Angiogenesis inhibitor -- Antiangiogenesis -- Apoptosis -- Atherosclerosis -- avb3 -- avb5 -- Cancer -- Cell adhesion molecules -- CM-101 123, 145 -- Collateral -- Combinatorial chemical libraries -- Cyclic RGD -- Cytokines -- Cytostatic -- Cytotoxic -- D -- Diabetes -- Diabetic retinopathy -- E -- Endothelial cells -- Endothelial migration -- Extracellular matrix -- F -- FGF 87, -- Fibroblast growth factor (FGF) -- G -- Gene therapy -- Growth factor(s) -- H -- Heparan sulfate -- Hyperoxia 68, 111, 112 -- I -- Imaging -- Immunoglobulin -- Inflammation -- Inflammatory diseases -- Integrins. Ischemia -- M -- Macular degeneration -- Matrix -- Matrix metalloproteinases -- Metastasis -- MMP -- N -- Neuropeptide Y -- O -- Ocular disease -- Oncology -- P -- Pericyte -- Plasminogen -- Proliferation -- Proteases -- R -- Remodeling -- Retina -- Revascularization -- S -- Screening -- Signal transduction -- Smooth muscle cell (SMC) -- Surrogate marker -- T -- Tecogalan 11, 145, 153, 155, 157 -- Therapeutic angiogenesis -- Thrombospondin -- Thymosin -- Tube formation -- Tumor angiogenesis -- Tyrosine kinase -- V -- Vascular remodeling -- VEGF -- VEGF receptors -- W -- Wound angiogenesis.
  • 摘要: The regulation of blood vessel growth underlies many normal biological processes such as reproduction, development, repair and wound healing. It also is a critical feature of pathological processes such as cancer, diabetic retinopathy, macular degeneration, inflammatory arthritis and ischemic heart disease.
  • 電子資源: https://dbs.tnua.edu.tw/login?url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=70655
  • 系統號: 005298601
  • 資料類型: 電子書
  • 讀者標籤: 需登入
  • 引用網址: 複製連結